/ Active, not recruitingPhase 4 A Prospective, Multicenter, Single-arm, Open-label, Interventional Phase IV Study to Evaluate the Safety and Efficacy of Idursulfase (r-DNA origin) (Elaprase™) in Indian Pediatric and Adult Population with Hunter Syndrome (Mucopolysaccharidosis II) - Nil
100 Clinical Results associated with Shire Biotech India Pvt Ltd.
0 Patents (Medical) associated with Shire Biotech India Pvt Ltd.
100 Deals associated with Shire Biotech India Pvt Ltd.
100 Translational Medicine associated with Shire Biotech India Pvt Ltd.